92 related articles for article (PubMed ID: 32294255)
1. Have incidence rates of liver cancer peaked in the United States?
Petrick JL; Florio AA; Loomba R; McGlynn KA
Cancer; 2020 Jul; 126(13):3151-3155. PubMed ID: 32294255
[TBL] [Abstract][Full Text] [Related]
2. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
3. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.
Petrick JL; Braunlin M; Laversanne M; Valery PC; Bray F; McGlynn KA
Int J Cancer; 2016 Oct; 139(7):1534-45. PubMed ID: 27244487
[TBL] [Abstract][Full Text] [Related]
4. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.
Petrick JL; Sahasrabuddhe VV; Chan AT; Alavanja MC; Beane-Freeman LE; Buring JE; Chen J; Chong DQ; Freedman ND; Fuchs CS; Gaziano JM; Giovannucci E; Graubard BI; Hollenbeck AR; Hou L; Jacobs EJ; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Purdue MP; Rosenberg L; Schairer C; Sesso HD; Sigurdson AJ; Wactawski-Wende J; Zeleniuch-Jacquotte A; Campbell PT; McGlynn KA
Cancer Prev Res (Phila); 2015 Dec; 8(12):1156-62. PubMed ID: 26391917
[TBL] [Abstract][Full Text] [Related]
5. Trends in Incidence and Mortality of Primary Liver Cancer in Lithuania 1998-2015.
Dulskas A; Kavaliauskas P; Zagminas K; Jancoriene L; Smailyte G
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33572744
[No Abstract] [Full Text] [Related]
6. Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Massarweh NN; El-Serag HB
Cancer Control; 2017; 24(3):1073274817729245. PubMed ID: 28975830
[TBL] [Abstract][Full Text] [Related]
7. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
Petrick JL; Kelly SP; Altekruse SF; McGlynn KA; Rosenberg PS
J Clin Oncol; 2016 May; 34(15):1787-94. PubMed ID: 27044939
[TBL] [Abstract][Full Text] [Related]
8. Telomere length and risk of cirrhosis, hepatocellular carcinoma, and cholangiocarcinoma in 63,272 individuals from the general population.
Gellert-Kristensen H; Bojesen SE; Tybjærg Hansen A; Stender S
Hepatology; 2024 Apr; 79(4):857-868. PubMed ID: 37732945
[TBL] [Abstract][Full Text] [Related]
9. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.
Florio AA; Ferlay J; Znaor A; Ruggieri D; Alvarez CS; Laversanne M; Bray F; McGlynn KA; Petrick JL
Cancer; 2020 Jun; 126(11):2666-2678. PubMed ID: 32129902
[TBL] [Abstract][Full Text] [Related]
10. Recent Trends in the Incidence of Gastric Cancer in the United States.
Liu KS; Raza SA; El-Serag HB; Thrift AP
J Clin Gastroenterol; 2024 Jan; 58(1):39-45. PubMed ID: 36413030
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study.
Curti S; Gallo M; Ferrante D; Bella F; Boschetti L; Casotto V; Ceppi M; Cervino D; Fazzo L; Fedeli U; Giorgi Rossi P; Giovannetti L; Girardi P; Lando C; Migliore E; Miligi L; Oddone E; Perlangeli V; Pernetti R; Piro S; Storchi C; Tumino R; Zona A; Zorzi M; Brandi G; Ferretti S; Magnani C; Marinaccio A; Mattioli S
Med Lav; 2024 Apr; 115(2):e2024016. PubMed ID: 38686579
[TBL] [Abstract][Full Text] [Related]
12. Global, regional and national burden of primary liver cancer by subtype.
Rumgay H; Ferlay J; de Martel C; Georges D; Ibrahim AS; Zheng R; Wei W; Lemmens VEPP; Soerjomataram I
Eur J Cancer; 2022 Jan; 161():108-118. PubMed ID: 34942552
[TBL] [Abstract][Full Text] [Related]
13. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics.
Macias RIR; Monte MJ; Serrano MA; González-Santiago JM; Martín-Arribas I; Simão AL; Castro RE; González-Gallego J; Mauriz JL; Marin JJG
Aging (Albany NY); 2021 Oct; 13(19):23416-23434. PubMed ID: 34633987
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis.
Brar G; Greten TF; Graubard BI; McNeel TS; Petrick JL; McGlynn KA; Altekruse SF
Hepatol Commun; 2020 Oct; 4(10):1541-1551. PubMed ID: 33024922
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Hepatocellular Carcinoma.
McGlynn KA; Petrick JL; El-Serag HB
Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):4-13. PubMed ID: 32319693
[TBL] [Abstract][Full Text] [Related]
16. Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database.
Yao Z; Dai C; Yang J; Xu M; Meng H; Hu X; Lin N
J Gastrointest Oncol; 2023 Feb; 14(1):312-324. PubMed ID: 36915450
[TBL] [Abstract][Full Text] [Related]
17. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort.
Goodrich JA; Walker D; Lin X; Wang H; Lim T; McConnell R; Conti DV; Chatzi L; Setiawan VW
JHEP Rep; 2022 Oct; 4(10):100550. PubMed ID: 36111068
[TBL] [Abstract][Full Text] [Related]
18. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
